Goserelin acetate
USP/1297205 - United States Pharmacopeia (USP) Reference Standard
Synonym: [D-Ser(tBu)6,Azagly10]-LHRH acetate salt
CAS Number: 145781-92-6
Empirical Formula (Hill Notation): C59H84N18O14
Molecular Weight: 1269.41
MDL Number: MFCD01747329
Linear Formula: C59H84N18O14
Product Type: Chemical
API family | goserelin |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C59H84N18O14.C2H4O2/c1 |
InChI key | IKDXDQDKCZPQSZ-JHYYTBFNSA |
manufacturer/tradename | USP |
SMILES string | CC(O)=O.CC(C)C[C@H](NC(=O |
storage temp. | −20°C |
Amino Acid Sequence: | Glp-His-Trp-Ser-Tyr-Ser(t |
Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Biochem/physiol Actions: | Goserelin is a synthetic analog of LHRH (leutinizing hormone releasing hormone). Goserelin is a LHRH agonist It is used in prostate cancer and breast cancer therapies and also in the treatment of endometriosis. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
Other Notes: | This product is part of the USP Biologics program. |
Symbol | GHS08 |
Signal word | Danger |
Hazard statements | H360 |
Precautionary statements | P201 - P280 - P308 + P313 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Storage Temp. | −20°C |
UNSPSC | 41116107 |